WebApr 5, 2024 · Each mL of Levothyroxine Sodium Injection also contains 10 mg Tromethamine, USP; 0.14 mg Sodium Iodide, USP; 6.48 mg Sodium Chloride, USP; and … WebLevothyroxine, at doses individualized according to patient response, is effective as replacement or supplemental therapy in hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine is also effective in the suppression of pituitary TSH secretion in the treatment or
Products - Amneal Pharmaceuticals
WebDec 15, 2024 · Levothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Levothyroxine sodium tablets are indicated as an adjunct to surgery and radioiodine … WebJan 2, 2024 · Levothyroxine Sodium (Accord Healthcare Inc.): FDA Package Insert, Page 3 Levothyroxine Sodium (Page 3 of 6) Accord Healthcare Inc. 2 January 2024 5.5 Worsening of Diabetic Control Addition of levothyroxine therapy in patients with diabetes mellitus may worsen glycemic control and result in increased antidiabetic agent or insulin requirements. state of alaska dpa email
Full Prescribing Information - amneal.com
WebJan 8, 2016 · SYNTHROID® Product Monograph Page 1 of 36 Date of Revision: January 8, 2016 and Control No. 185008 PRODUCT MONOGRAPH Pr SYNTHROID® levothyroxine sodium tablets, USP 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg and 300 mcg Thyroid Hormone BGP Pharma ULC Date … WebLevothyroxine Sodium for Injection therapy for patients with previously undiagnosed endocrine disorders, including adrenal insufficiency, hypopituitarism, and diabetes insipidus, may worsen symptoms of these endocrinopathies. ... The prescriber should be aware of this fact and should consult appropriate reference sources (e.g., package inserts ... WebLevothyroxine sodium tablets are indicated as a replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression state of alaska dpa